Work

A phase II trial of dasatinib in patients with unresectable locally advanced or stage IV mucosal, acral, and solar melanomas: An Eastern Cooperative Oncology Group study (E2607).

Year: 2012

Type: conference-abstract

Source: Journal of Clinical Oncology

DOI: 10.1200/jco.2012.30.15_suppl.8522

Authors: Kevin Kalinsky, Sandra J. Lee, Donald P. Lawrence, A. John Iafrate, Darrell R. Borger, Bruce Jeffrey Averbook, Ahmad A. Tarhini, John M. Kirkwood

Institutions: Columbia University Irving Medical Center, Dana-Farber Cancer Institute, Massachusetts General Hospital, MetroHealth Medical Center, University of Pittsburgh Medical Center, UPMC Hillman Cancer Center

Language: English

Topic: Melanoma and MAPK Pathways

Subfield: Molecular Biology

Field: Biochemistry, Genetics and Molecular Biology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2590617115

Cites:

Cited by: 9

Related to: 10